China Approves Clinical Trials of German COVID-19 Vaccine

November 26, 2020

China Approves Clinical Trials of German COVID-19 Vaccine

China regulators have approved the clinical trial findings of a German COVID-19 vaccine. Preliminary clinical trial data has found the vaccine produced by BioNTech to by 90% effective. The vaccine will be produced by Shanghai Fosun Pharmaceutical (Group) Co., Ltd in China and by Pfizer Inc. globally. Yourway has a local depot with 11,700 square foot capacity located in Beijing, China and is well equipped to serve all of Asia.

Back to Index

Stay Connected

Want to stay informed about the latest news, updates, and opportunities at Yourway?

Join our newsletter mailing list to never miss an update!

Media

Upcoming Events

Longwood Healthcare Leaders

October 27-28, 2025
Mandarin Oriental Hotel, Boston

Schedule a Meeting

Precision in Pharma Supply Chain & Logistics Summit

November 17-18, 2025
Revere Hotel Boston Common

Schedule a Meeting

Media

Articles

Mitigating Risk in Drug Development: The Strategic Role of Phase I Research Units

Open chat

Hello! How can I help you?